Navigation Links
Driver of anthrax toxicity could lead to late-stage therapy

A study in the March 24 Cell reports the discovery of a gene that drives anthrax bacteria's toxic effects. The gene could offer a potential new target for countermeasures against the lethal toxin, according to the researchers.

Such therapies might have the potential to protect against anthrax during the late stages of the disease, after antibiotics have lost their therapeutic value, they added.

The team found that human cells deficient in the so-called LDL receptor-related protein (LRP6) become resistant to anthrax toxin. Furthermore, antibodies against LRP6 protected cells from anthrax toxicity, reported study authors Wensheng Wei and Stanley Cohen of the Stanford University School of Medicine in collaboration with others at Stanford and the National Institutes of Health. The level of anthrax protection afforded by the antibodies rose with increasing dose.

Anthrax is a lethal disease of humans and other animals caused by the spore-forming bacteria Bacillus anthracis, which has been the focus of biological interest and bioterrorism concern. The virulence of the bacteria depends on separate complexes formed by interaction of a carrier protein, protective antigen, with lethal and edema factors responsible for the toxic effects and swelling that impairs the host's immune response.

In the current study, the researchers inactivated genes randomly in human cells. They then examined the mutated cells for resistance to anthrax toxin in an effort to identify host genes that have important roles in infection, with the hope of finding possible new targets for therapies aimed at the host instead of the bacteria. The method allows for the identification of required host cell genes without pre-conceptions about their potential to play a role, the study authors said.

The study revealed that LRP6 acts as a co-receptor, enabling cells to take up anthrax toxin through its interactions with two distinct cell- surface proteins earlier shown to bi
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Scientists seek answers on what activates deadly anthrax spores
2. Antibodies from plants protect against anthrax
3. Defensins neutralize anthrax toxin
4. Critical step traced in anthrax infection
5. US Army plans to bulk-buy anthrax
6. New antibody shows promise as cure for anthrax
7. Effective, safe anthrax vaccine can be grown in tobacco plants
8. UCSD study finds anthrax toxins also harmful to fruit flies
9. Scientists design potent anthrax toxin inhibitor
10. Newly discovered protein kills anthrax bacteria by exploding their cell walls
11. Combating anthrax: Results of study published this month as researchers look for a better vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Driver anthrax toxicity could lead late stage therapy

(Date:10/31/2014)... his team have been studying the behavior of ... Alps for years. They observed that ravens slowly ... and playing. However, they also observed that these ... individual. Although in about 50 % of the ... the two affiliating ravens, intervening can be potentially ...
(Date:10/30/2014)... Mich. – When most animals begin life, cells immediately ... a vital organ. However, mammals, including humans, are special. ... different first choice – to become the protective placenta ... during this critical first step that research from Michigan ... in the current issue of PLOS Genetics ...
(Date:10/30/2014)... Carolina State University researchers have developed a suite of ... dogs and humans, which has applications in everything from ... pets. , "We,ve developed a platform for computer-mediated communication ... new avenues for interpreting dogs, behavioral signals and sending ... David Roberts, an assistant professor of computer science at ...
Breaking Biology News(10 mins):Identifying the source of stem cells 2New tech aims to improve communication between dogs and humans 2
... 2011) -- Scientists at Weill Cornell Medical College used genetic ... engineered for the study of cleft lip and cleft palate. ... treat the conditions in humans. Cleft lip and cleft ... requiring multiple cycles of surgery, speech therapy and orthodontics. To ...
... zoological journal ZooKeys published by Pensoft ... says an analysis dedicated to journal,s jubilee 150th issue, By ... 10,000 pages and 420 articles (to compare with 4,962 pages ... 2008, ZooKeys published more than 19,000 pages and ...
... has come from the fossil record, but how accurately does that ... "It,s a question that goes back a long way to ... tried to understand what it tells us about the history of ... In fact, the fossil record can tell us a great ...
Cached Biology News:Cleft lip corrected genetically in mouse model 2Cleft lip corrected genetically in mouse model 3Growth through innovations and open access: The journal ZooKeys on point for digital taxonomy 2Ancient environment led to Earth's current marine biodiversity 2
(Date:10/30/2014)... Diego, CA (PRWEB) October 30, 2014 ... announced today that they have manually curated public data ... and non profit customers. the data is now ... manually curates and unifies public and internal data sources ... value and knowledge out of the data that becomes ...
(Date:10/30/2014)... Spartan Bioscience announced today that Health ... . It detects CYP2C19 genetic mutations in less than ... Spartan RX CYP2C19 System is the first near-patient DNA ... Canada. Due to the system’s ease of use, Health ... healthcare professionals such as doctors, nurses, pharmacists, and laboratory ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Avure Technologies celebrates ... 525L, the newest member of its fleet of high volume ... reaching an anniversary as we return to PackExpo this year, ... ago in Las Vegas,” said Jeff Williams, CEO at Avure. ... and we’re pleased to be meeting the challenges of market ...
(Date:10/30/2014)... Oct. 30, 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a company overview at the Nomura ... ET in Boston, MA. ... the "Investors & Media" section of the Company,s website, ... website within 48 hours and will be archived for a ...
Breaking Biology Technology:Rancho BioSciences Manually Curated TCGA Data Sets Available 2Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
... INCOM Inc., the world,s leading commercial manufacturer of ... acquired Paradigm Optics, a manufacturer of polymer fiber optic ... intellectual property related to the manufacture and sale of ... capital equipment.  Paradigm Optics President & CEO Mr. David ...
... , part of Vocollect, a business unit of ... Pine Grove Nursing Center has implemented AccuNurse® voice ... care to patients and residents, while preparing for 2014 healthcare ... Grove CNAs to observe and accurately document care needs while ...
... Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI), which ... announced that Lawrence A. Siebert, President and Chief Executive ... Francisco at approximately 5:30 pm Eastern Time (2:30 pm ... The conference will be simultaneously webcast over the ...
Cached Biology Technology:INCOM Inc. Announces Acquisition of Paradigm Optics 2Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery 2Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery 3Chembio Presenting at Biotech Conference 2Chembio Presenting at Biotech Conference 3